With a growing number of states enacting drug price transparency requirements, we looked into what traction state transparency reports get on social media. The key takeaway: the states may have imposed these new reporting rules, but they are doing almost nothing to make sure they get noticed.

The data shows the reports have driven almost no discussion online.

Of the 23 reports we identified since 2016, only two garnered any social media shares: Colorado’s 2020 Insulin report (167 Facebook Shares | 38 Twitter shares) and California’s Q1-Q2 2020 WAC report (9 Facebook Shares | 24 Twitter Shares).

It’s actually not hard to figure out why. The reports themselves are often buried deep into state government websites. In other words (pardon the dad joke), transparency reports are hard to see.

Setting aside the issue of whether the reports still represent a reputational risk for pharmaceutical companies and other drug supply chain members, the lack of social chatter might add to ongoing debate about the effectiveness of state-level transparency initiatives. Earlier this month, we highlighted the challenges these laws present, including the ambiguous language in many of the bills and how requirements vary from state to state. Further, a 2019 Journal of the American Medical Association study argued the laws don’t go far enough in exposing which supply chain participants are culpable.

If you want to dive even further into what’s happening at the state level, check out our previous research into how states are tackling PBM regulation.

CA Prescription Drug Wholesale Acquisition Cost (WAC) Increases 2020
CA UPDATED Q1-Q4 2019 Prescription Drugs WAC Increases 2019
CA Prescription Drug Cost Transparency Report 2018
CA Prescription Drug Cost Transparency Report (SB 17) 2017
CO Prescription Drug Insulin Pricing Report 2020
CT Employee_Retiree Health Plan Top 25 Outpatient Prescription Drugs 2020
CT Top Twenty-Five Most Prescribed Drugs For The State Medicaid System 2019
IA Pharmacy Benefit Manager 2020 Annual Report 2020
LA Pharmacy Benefit Manager Annual Transparency Reporting 2020
ME Prescription Drug Costs and Utilization in Maine at Retail and Mail Order Pharmacies 2019
NV Drug Transparency Report: 2020 Essential Drugs 2020
NV Drug Transparency Report: 2019 Essential Diabetes Drugs 2019
NV Essential Diabetes Drugs Price Increase Report 2018
NV Supplemental Report: 2017 Essential Diabetes Drugs 2017
OR 2020 Insurer Report Data 2020
OR  Insurer Reports on Prescription Drugs Drug Price Transparency Program 2019
OR Prescription Drug Price Transparency Results and Recommendations 2019
TX Price Increase Reporting 2020
VT DVHA Drug Lists 2019 2019
VT AGO Pharmacy Transparency Report 2019
VT AGO Pharmacy Transparency Report 2017
VT AGO Pharmacy Transparency Report 2016
WI Report of the Governor’s Task Force on Reducing Prescription Drug Prices 2020